Cengild Medical Berhad (0243) — Capital Reinvestment Ratio
Cengild Medical Berhad (0243) has a Capital Reinvestment Ratio of 39.05x as of December 2025, meaning it reinvests 39% of its operating cash flow (RM947.00K) in capital expenditures (RM36.98 Million). See Cengild Medical Berhad (0243) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Cengild Medical Berhad Capital Reinvestment Ratio (2020–2025)
This chart tracks Cengild Medical Berhad's Capital Reinvestment Ratio across 6 annual periods. Check 0243 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Cengild Medical Berhad (2020–2025)
Year-by-year Capital Reinvestment Ratio for Cengild Medical Berhad from 2020 to 2025. For live market cap and broader valuation context, see market cap of Cengild Medical Berhad.
| Year | Reinvestment Ratio | Operating CF (MYR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.32x | RM16.08 Million | RM37.26 Million | ▲ +90.5% |
| 2024 | 1.22x | RM12.94 Million | RM15.73 Million | ▲ +686.2% |
| 2023 | 0.15x | RM13.76 Million | RM2.13 Million | ▲ +408.4% |
| 2022 | 0.03x | RM14.05 Million | RM427.67K | ▼ -74.4% |
| 2021 | 0.12x | RM14.30 Million | RM1.70 Million | ▲ +118.8% |
| 2020 | 0.05x | RM11.24 Million | RM610.08K | — |